Hypoxemia due to sleep apnea associated with risk of lung cancer reoccurrence: Study Dr. Kamal Kant Kohli25 Jun 2024 8:00 PM ISTA new study to be presented at the SLEEP 2024 annual meeting is the first to find that episodic hypoxemia and hypoxic burden related to obstructive...
Chat GPT may prouce structured, summarized radiology reports for pancreatic ductal adenocarcinoma: Study Medha Baranwal25 Jun 2024 4:00 AM ISTCanada: In a groundbreaking development, large language models (LLMs) are poised to transform the landscape of pancreatic cancer diagnosis and...
Antipsychotic Use Associated with Increased Gynecological Cancer Risk: BMC Jacinthlyn Sylvia25 Jun 2024 2:45 AM ISTA recent study published in the BMC Cancer explored the potential link between antipsychotic medication and an increased risk of gynecological...
Air pollution can increase cardiovascular risk for cancer patients, finds study Dr. Kamal Kant Kohli23 Jun 2024 9:15 PM ISTModern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including...
Early Menopause and Hormone Therapy may Impact Lung Health: Insights from PLCO Trial Analysis Medha Baranwal23 Jun 2024 8:45 PM ISTUSA: A secondary analysis of data from the PLCO Trial has revealed intriguing insights into the relationship between early menopause, hormone...
Takeda gets European Commission approval for Fruzaqla for previously treated metastatic Colorectal cancer Ruchika Sharma23 Jun 2024 12:00 PM ISTFRUZAQLA is a selective oral inhibitor of all three VEGF receptors (-1, -2 and -3). VEGFR inhibitors play a pivotal role in blocking tumor...
Bristol Myers Squibb application for subcutaneous Nivolumab validated by EMA Ruchika Sharma23 Jun 2024 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated the extension application to introduce...
Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer Ruchika Sharma22 Jun 2024 11:11 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
Celecoxib could reduce risk of colon cancer recurrence for subset of patients, claims study Dr. Kamal Kant Kohli22 Jun 2024 7:45 AM ISTAn analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...
Glowing dye helps surgeons eradicate prostate cancer, claims research Dr. Kamal Kant Kohli20 Jun 2024 8:00 PM ISTA glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer...
Sunshine in a Pill: High-Dose Oral Vitamin D Targets Cancer Treatment Skin Toxicities, study reveals Medha Baranwal20 Jun 2024 8:00 AM ISTUSA: As cancer treatment advances, so do strategies to manage its side effects. A new frontier in supportive care has emerged with high-dose oral...
Androgen receptor signaling inhibitors associated with Increased cardiovascular risks ,warns study Jacinthlyn Sylvia19 Jun 2024 10:15 PM ISTCardiovascular (CV) events remain a significant cause of mortality among men with advanced and metastatic prostate cancer (PCa). A recent study...
